Efficacy and Safety of Lomitapide in Japanese Patients With HoFH on Concurrent Lipid-Lowering Therapy
Status:
Completed
Trial end date:
2015-12-17
Target enrollment:
Participant gender:
Summary
Study to Evaluate the Efficacy and Safety of Lomitapide in Japanese Patients with Homozygous
Familial Hypercholesterolemia (HoFH) on Concurrent Lipid-Lowering Therapy.